Sens Stock: Eyeing 38 Cents for All-Time Low Buy Opportunity
Sens stock, a compelling asset in the realm of healthcare technology, is catching the attention of investors as it approaches the 38-cent mark, representing all-time lows. With the formation of a double bottom and falling wedge pattern, this potential buy opportunity could pave the way for a remarkable...
Sens recent earnings was quite good but the stock has sold off anyway. I have been waiting patiently for this moment as we could be reaching the bottoming phase based on the chart analysis of the bearish shark.
What narrative could make it spike up in price?
Please do your DD as this is not a financial advice.
we go bounce at our support 2.18$, We have strong resistant and reversal area at 2.70$, we should have 4h candle to confirm the bullish momentum .
if we didn't hold the above support, we will see buying pressure agin at 1.72$
SENS Senseonics is waiting for FDA`s approval for the 180-day version of its Eversense CGM system.
Eversense can generate as much as $200 million in sales by 2025.
HC Wainwright sees a 6usd price target for it.
And let`s not forget it`s a meme stock.
Either a Wave 4 WXY pattern or a more general turnaround. Both scenarios are bearish. Note divergences and dropping momentum also.
We are not in the business of getting every prediction right, no one ever does and that is not the aim of the game. The Fibonacci targets going down are highlighted in purple with invalidation in red. Fibonacci goals, it is prudent...
Pulled SENS back up again after a few weeks and see that it's still holding the same fib and trendline levels as it was when we first drew out the fib retracement. It's also now holding the 50DMA consistently as it steadily rises. For some context, this company develops and commercializes continuous glucose monitoring systems for diabetes patients. Senseonics...
The thing about SENS is that it's been a company crushing it in 2021. When it was first discussed this year it was still trading below $1. Despite recent volatility, it's up significantly year-to-date. I think volume remains steady but definitely on the lower end of the range. But good data from the last presentation on its PROMISE study seems to have sparked...
-Shares of Senseonics (NYSEMKT:SENS) are on the march in Friday’s pre-market action stock after the medtech firm reported positive test results for its glucose-monitoring system. SENS stock was up more than 30% at 8:30 a.m. Eastern.
-SENS stock closed Thursday at $2.05 a share after surging over the past six month. The shares used to trade deep in penny stock...
It looks like wave 2 has completed for SENS. They had a conference today march 9th about some things that were already known to us, but they made some things more clear. Quick summary of this conference:
- Accuracy of the current device is best in class with a MARD of 8.5%
- Medicare National Coverage as of Jan 1, 2021:
- Avg "Supply Cost" (I assume this is for...
Buddy and I found these potential trends in SENS. It's lower due to the recents news around the FDA approval. But I could see both potential trends happening based on the past. Who knows.
This stock is definitely on my watchlist to test it out depending on what further info comes out.